Format
Sort by

Send to

Choose Destination

Search results

Items: 14

1.

Meditation and Medication-What About a Middle Path?

Lovas DA, Lutz J, Schuman-Olivier Z.

JAMA Psychiatry. 2016 Dec 1;73(12):1294-1295. doi: 10.1001/jamapsychiatry.2016.1471. No abstract available.

PMID:
27784039
2.

Mindfulness and Cardiovascular Disease Risk: State of the Evidence, Plausible Mechanisms, and Theoretical Framework.

Loucks EB, Schuman-Olivier Z, Britton WB, Fresco DM, Desbordes G, Brewer JA, Fulwiler C.

Curr Cardiol Rep. 2015 Dec;17(12):112. doi: 10.1007/s11886-015-0668-7. Review.

3.
4.

Emerging adult age status predicts poor buprenorphine treatment retention.

Schuman-Olivier Z, Weiss RD, Hoeppner BB, Borodovsky J, Albanese MJ.

J Subst Abuse Treat. 2014 Sep;47(3):202-12. doi: 10.1016/j.jsat.2014.04.006.

5.

Finding the right match: mindfulness training may potentiate the therapeutic effect of nonjudgment of inner experience on smoking cessation.

Schuman-Olivier Z, Hoeppner BB, Evins AE, Brewer JA.

Subst Use Misuse. 2014 Apr;49(5):586-94. doi: 10.3109/10826084.2014.850254.

6.

Clinician beliefs and attitudes about buprenorphine/naloxone diversion.

Schuman-Olivier Z, Connery H, Griffin ML, Wyatt SA, Wartenberg AA, Borodovsky J, Renner JA Jr, Weiss RD.

Am J Addict. 2013 Nov-Dec;22(6):574-80. doi: 10.1111/j.1521-0391.2013.12024.x.

7.

Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes.

Schuman-Olivier Z, Hoeppner BB, Weiss RD, Borodovsky J, Shaffer HJ, Albanese MJ.

Drug Alcohol Depend. 2013 Oct 1;132(3):580-6. doi: 10.1016/j.drugalcdep.2013.04.006.

8.

How Does Mindfulness Meditation Work? Proposing Mechanisms of Action From a Conceptual and Neural Perspective.

Hölzel BK, Lazar SW, Gard T, Schuman-Olivier Z, Vago DR, Ott U.

Perspect Psychol Sci. 2011 Nov;6(6):537-59. doi: 10.1177/1745691611419671.

PMID:
26168376
9.

Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers.

Schuman-Olivier Z, Albanese M, Nelson SE, Roland L, Puopolo F, Klinker L, Shaffer HJ.

J Subst Abuse Treat. 2010 Jul;39(1):41-50. doi: 10.1016/j.jsat.2010.03.014.

PMID:
20434868
10.

The use of palliative sedation for existential distress: a psychiatric perspective.

Schuman-Olivier Z, Brendel DH, Forstein M, Price BH.

Harv Rev Psychiatry. 2008;16(6):339-51. doi: 10.1080/10673220802576917. Review.

PMID:
19085388
11.

A preliminary study of spiritual self-schema (3-S(+)) therapy for reducing impulsivity in HIV-positive drug users.

Margolin A, Schuman-Olivier Z, Beitel M, Arnold RM, Fulwiler CE, Avants SK.

J Clin Psychol. 2007 Oct;63(10):979-99.

PMID:
17828761
12.

Psychometric properties of a Chinese version of the Psychological Mindedness Scale.

Hua W, Beitel M, Schuman-Olivier Z, Declan B.

J Am Psychoanal Assoc. 2007 Winter;55(1):300-5. No abstract available.

PMID:
17432509
13.

Reflections by inner-city drug users on a Buddhist-based spirituality-focused therapy: a qualitative study.

Beitel M, Genova M, Schuman-Olivier Z, Arnold R, Avants SK, Margolin A.

Am J Orthopsychiatry. 2007 Jan;77(1):1-9.

PMID:
17352579
14.

A controlled study of a spirituality-focused intervention for increasing motivation for HIV prevention among drug users.

Margolin A, Beitel M, Schuman-Olivier Z, Avants SK.

AIDS Educ Prev. 2006 Aug;18(4):311-22.

PMID:
16961448
Items per page

Supplemental Content

Loading ...
Support Center